Safeguard in search for Euro distribution partner
This article was originally published in Clinica
US-based Safeguard Medical Devices is looking for a partner to distribute its Disintegrator Plus home-use needle and lancet destroying device in Europe. The device, which is marketed mainly at diabetics, won FDA approval for home use in April and the company is expecting CE-Marking approval within the next couple of months. The American Diabetes Association, which has voiced concern over the dangers posed by the 3.6 billion syringes discarded in the US every year, has also given the device its stamp of approval.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.